Page last updated: 2024-09-04

6-hydroxytryptamine and Melanoma

6-hydroxytryptamine has been researched along with Melanoma in 1 studies

*Melanoma: A malignant neoplasm derived from cells that are capable of forming melanin, which may occur in the skin of any part of the body, in the eye, or, rarely, in the mucous membranes of the genitalia, anus, oral cavity, or other sites. It occurs mostly in adults and may originate de novo or from a pigmented nevus or malignant lentigo. Melanomas frequently metastasize widely, and the regional lymph nodes, liver, lungs, and brain are likely to be involved. The incidence of malignant skin melanomas is rising rapidly in all parts of the world. (Stedman, 25th ed; from Rook et al., Textbook of Dermatology, 4th ed, p2445) [MeSH]

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kawano, Y; Yamazaki, Y1

Other Studies

1 other study(ies) available for 6-hydroxytryptamine and Melanoma

ArticleYear
N-(3,5-dihydroxybenzoyl)-6-hydroxytryptamine as a novel human tyrosinase inhibitor that inactivates the enzyme in cooperation with l-3,4-dihydroxyphenylalanine.
    Chemical & pharmaceutical bulletin, 2010, Volume: 58, Issue:11

    Topics: Cell Line, Tumor; Enzyme Inhibitors; Humans; Levodopa; Melanoma; Monophenol Monooxygenase; Serotonin

2010